Intellectual property law in China has steadily improved in recent years, and there has been a considerable increase in the number of patents filed in China. This article is a Q&A with Finnegan partner Ningling Wang: Ms. Wang, whose practice involves several areas, including pharmaceuticals, chemicals, medical devices, and nanotechnology, discusses the evolving climate for intellectual property and patents in China. Ms. Wang has extensive experience working with multinational big-pharma companies and domestic organizations in China. During the interview, Ms. Wang answers questions about how much the patent climate has improved in China in recent years (a lot); whether patent activity has increased (domestic China patent applications filed by foreign companies has greatly increased); and whether the Chinese government is good about encouraging companies to come in and conduct innovative research (yes). Ms. Wang concludes, however, that the growing system in China and the legal framework for venture capital arrangements still involve uncertainties.
Press Release
October 6, 2026
Commentary
Federal Circuit Revives Whistleblower Complaint Over VA's AI Claims-Processing Tool
September 25, 2026
Award/Ranking
Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027
September 24, 2026
Press Release
Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower
September 23, 2026
Award/Ranking
Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026
September 23, 2026
Award/Ranking
September 11, 2026
Commentary
Uncrustables Fame Ruling Sets Up Functionality Fight Over Crimped Edge
September 11, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.